Aebersold Sarah sold BLFS

February 21, 2024 · Form 4 insider transaction

Aebersold Sarah sold 58 shares of BioLife Solutions, Inc. at $17.35 per share, a transaction worth $1.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
58
Price
$17.35
Total value
$1.0K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 21, 2024
Filing dateFebruary 23, 2024
Shares owned after41,806
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

View the original Form 4 on SEC EDGAR